Wells Fargo initiated coverage on United Therapeutics with a new price target

12/8/23 8:04:43 AM ET

Biotechnology: Pharmaceutical Preparations

Health Care

Wells Fargo initiated coverage of United Therapeutics with a rating of Overweight and set a new price target of $309.00

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$UTHR

Date	Price Target	Rating	Analyst
6/2/2025	$405.00	Overweight	Cantor Fitzgerald
4/25/2025		Overweight → Equal Weight	Wells Fargo
4/21/2025	$314.00	Underperform → Neutral	BofA Securities
7/11/2024	$310.00 → $321.00	Overweight → Equal-Weight	Morgan Stanley
2/12/2024	$213.00 → $215.00	Sell → Neutral	Goldman
2/5/2024	$330.00	Outperform	Leerink Partners
12/8/2023	$309.00	Overweight	Wells Fargo
12/6/2022	$320.00	Buy	UBS